According to NGM Biopharmaceuticals's latest financial reports the company's current revenue (TTM ) is $4.41 Million USD. In 2022 the company made a revenue of $55.33 Million USD a decrease over the revenue in the year 2021 that were of $77.88 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.